Alliance Pharma plc (LON:APH – Get Free Report)’s stock price hit a new 52-week high on Wednesday . The company traded as high as GBX 48 ($0.62) and last traded at GBX 47.50 ($0.62), with a volume of 820217 shares changing hands. The stock had previously closed at GBX 46.25 ($0.60).
Alliance Pharma Stock Performance
The company has a market capitalization of £256.77 million, a price-to-earnings ratio of -791.67, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The stock has a 50 day moving average price of GBX 42.85 and a two-hundred day moving average price of GBX 38.62.
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Read More
- Five stocks we like better than Alliance Pharma
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- What a Trump Win Looks Like for the Market Now and Into 2025
- What Are Some of the Best Large-Cap Stocks to Buy?
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- ESG Stocks, What Investors Should Know
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
